1-855-378-42281-855-378-4228
One of the outpatient rehab options for individuals in Waterbury who are struggling with opioid abuse and addiction is opioid maintenance therapy. Some centers and doctors are certified to administer specific meds to opioid dependent individuals, many of which are opioids themselves and are addictive. With low enough amounts however, the user doesn't experience being high but also does not experience acute cravings and is not experiencing opioid withdrawal. Methadone is the first med tried for this reason, but there are alternative choices currently to choose from.
Methadone is an opioid and is meant to be taken at an outpatient clinic certified to administer the drug, which is taken on a daily basis as a pill or liquid. The price of the drug is around $150 per month. Buprenorphine is also an opioid-based drug, and is in pill form often taken every other day. But different from Methadone which can only be dispensed in highly well-regulated medical centers, Buprenorphine can be prescribed and administered in doctor's offices. The cost monthly of buprenorphine is about $300 per month for the generic of the med. There is also a type of buprenorphine that contains the ingredient naloxone, which is a drug that reverses the effects of opiates. A person consuming this version of the drug, also known as Suboxone, would find it more difficult to get high from opioids if they relapsed while taking the drug. It is also taken every day, and is priced approximately $450 /month. Naltrexone is an additional med taken in opioid maintenance therapy, but unlike the other medications aforementioned it's an opioid blocker and isn't an opiate. There is an option to take this medication as a monthly injection, and that is called Vivitrol. As an opioid blocker, the drug prevents an individual from getting high from opioids, and in turn lowers the risk associated with relapse. This daily injection costs in the range of $1000 to $1200 per month.
For All Alcohol and Drug Rehab Programs In Waterbury, Click Here.
